2023-2029 Global Genetically Engineered Vaccines for Livestock Industry Research & Trends Analysis Report

Tables and Figures

Table 1. Genetically Engineered Vaccines for Livestock Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Genetically Engineered Vaccines for Livestock Market Restraints
Table 3. Genetically Engineered Vaccines for Livestock Market Trends
Table 4. Genetically Engineered Vaccines for Livestock Industry Policy
Table 5. Global Genetically Engineered Vaccines for Livestock Revenue by Company, 2018-2023, US$ million
Table 6. Global Genetically Engineered Vaccines for Livestock Revenue Market Share by Company, 2018-2023
Table 7. Global Genetically Engineered Vaccines for Livestock Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Genetically Engineered Vaccines for Livestock Sales Volume Market Share by Company, 2018-2023
Table 9. Global Genetically Engineered Vaccines for Livestock Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Genetically Engineered Vaccines for Livestock Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Genetically Engineered Vaccines for Livestock Mergers & Acquisitions, Expansion Plans
Table 12. Global Genetically Engineered Vaccines for Livestock Manufacturers Product Type
Table 13. China Genetically Engineered Vaccines for Livestock Revenue by Company, 2018-2023, US$ million
Table 14. China Genetically Engineered Vaccines for Livestock Revenue Market Share by Company, 2018-2023
Table 15. China Genetically Engineered Vaccines for Livestock Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Genetically Engineered Vaccines for Livestock Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Genetically Engineered Vaccines for Livestock Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Genetically Engineered Vaccines for Livestock Import & Export Trends
Table 19. Main Sources of China Genetically Engineered Vaccines for Livestock Import
Table 20. Export Destination of China Genetically Engineered Vaccines for Livestock
Table 21. Global Headquarters and Manufacturing Base of Genetically Engineered Vaccines for Livestock Manufacturers
Table 22. Global Major Manufacturers, Genetically Engineered Vaccines for Livestock Capacity Expansion and Future Plans
Table 23. Global Genetically Engineered Vaccines for Livestock Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Genetically Engineered Vaccines for Livestock Production by Region, 2018-2023, (K Units)
Table 25. Global Genetically Engineered Vaccines for Livestock Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Genetically Engineered Vaccines for Livestock Upstream (Raw Materials)
Table 27. Global Genetically Engineered Vaccines for Livestock Typical Customers
Table 28. Genetically Engineered Vaccines for Livestock Typical Distributors
Table 29. By Type, Global Genetically Engineered Vaccines for Livestock Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Genetically Engineered Vaccines for Livestock Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Genetically Engineered Vaccines for Livestock Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Genetically Engineered Vaccines for Livestock Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Genetically Engineered Vaccines for Livestock Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Genetically Engineered Vaccines for Livestock Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Genetically Engineered Vaccines for Livestock Revenue Market Share, 2018-2029
Table 37. By Country, Global Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2018-2029
Table 39. Merck Company Information, Head Office, Market Area and Industry Position
Table 40. Merck Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 41. Merck Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck Company Profile and Main Business
Table 43. Merck Recent Developments
Table 44. GSK Company Information, Head Office, Market Area and Industry Position
Table 45. GSK Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 46. GSK Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. GSK Company Profile and Main Business
Table 48. GSK Recent Developments
Table 49. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 50. Sanofi Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 51. Sanofi Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Sanofi Company Profile and Main Business
Table 53. Sanofi Recent Developments
Table 54. Zoties Company Information, Head Office, Market Area and Industry Position
Table 55. Zoties Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 56. Zoties Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Zoties Company Profile and Main Business
Table 58. Zoties Recent Developments
Table 59. Elanco Company Information, Head Office, Market Area and Industry Position
Table 60. Elanco Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 61. Elanco Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Elanco Company Profile and Main Business
Table 63. Elanco Recent Developments
Table 64. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 65. Boehringer Ingelheim Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 66. Boehringer Ingelheim Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Boehringer Ingelheim Company Profile and Main Business
Table 68. Boehringer Ingelheim Recent Developments
Table 69. Indian Immunologicals Company Information, Head Office, Market Area and Industry Position
Table 70. Indian Immunologicals Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 71. Indian Immunologicals Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Indian Immunologicals Company Profile and Main Business
Table 73. Indian Immunologicals Recent Developments
Table 74. China Animal Husbandry Industry Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
Table 75. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 76. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. China Animal Husbandry Industry Co.,Ltd. Company Profile and Main Business
Table 78. China Animal Husbandry Industry Co.,Ltd. Recent Developments
Table 79. Yebio Bioengineering Co., Ltd Of Qingdao Company Information, Head Office, Market Area and Industry Position
Table 80. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 81. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Yebio Bioengineering Co., Ltd Of Qingdao Company Profile and Main Business
Table 83. Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments
Table 84. Jinyu Bio-technology Co.,ltd. Company Information, Head Office, Market Area and Industry Position
Table 85. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 86. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Jinyu Bio-technology Co.,ltd. Company Profile and Main Business
Table 88. Jinyu Bio-technology Co.,ltd. Recent Developments
Table 89. HVRI Company Information, Head Office, Market Area and Industry Position
Table 90. HVRI Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 91. HVRI Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. HVRI Company Profile and Main Business
Table 93. HVRI Recent Developments
Table 94. Ringpu Biology Company Information, Head Office, Market Area and Industry Position
Table 95. Ringpu Biology Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 96. Ringpu Biology Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Ringpu Biology Company Profile and Main Business
Table 98. Ringpu Biology Recent Developments
Table 99. Kyoto Biken Laboratories Company Information, Head Office, Market Area and Industry Position
Table 100. Kyoto Biken Laboratories Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 101. Kyoto Biken Laboratories Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Kyoto Biken Laboratories Company Profile and Main Business
Table 103. Kyoto Biken Laboratories Recent Developments
Table 104. FATRO Company Information, Head Office, Market Area and Industry Position
Table 105. FATRO Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 106. FATRO Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. FATRO Company Profile and Main Business
Table 108. FATRO Recent Developments
Table 109. Ceva Santé Animale Company Information, Head Office, Market Area and Industry Position
Table 110. Ceva Santé Animale Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 111. Ceva Santé Animale Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Ceva Santé Animale Company Profile and Main Business
Table 113. Ceva Santé Animale Recent Developments
Table 114. Pulike Biological Engineering,Inc. Company Information, Head Office, Market Area and Industry Position
Table 115. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 116. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Pulike Biological Engineering,Inc. Company Profile and Main Business
Table 118. Pulike Biological Engineering,Inc. Recent Developments
Table 119. Wuhan Hvsen Biotechnology CO.,LTD Company Information, Head Office, Market Area and Industry Position
Table 120. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 121. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Wuhan Hvsen Biotechnology CO.,LTD Company Profile and Main Business
Table 123. Wuhan Hvsen Biotechnology CO.,LTD Recent Developments
Table 124. Jinhe Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 125. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 126. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Jinhe Biotechnology Co., Ltd. Company Profile and Main Business
Table 128. Jinhe Biotechnology Co., Ltd. Recent Developments
Table 129. Shanghai Shen Lian Biomedical Corporation Company Information, Head Office, Market Area and Industry Position
Table 130. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 131. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Shanghai Shen Lian Biomedical Corporation Company Profile and Main Business
Table 133. Shanghai Shen Lian Biomedical Corporation Recent Developments
Table 134. Qingdao Vland Biotech INC. Company Information, Head Office, Market Area and Industry Position
Table 135. Qingdao Vland Biotech INC. Genetically Engineered Vaccines for Livestock Models, Specifications and Application
Table 136. Qingdao Vland Biotech INC. Genetically Engineered Vaccines for Livestock Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 137. Qingdao Vland Biotech INC. Company Profile and Main Business
Table 138. Qingdao Vland Biotech INC. Recent Developments
List of Figure
Figure 1. Genetically Engineered Vaccines for Livestock Picture
Figure 2. By Revenue, Global Genetically Engineered Vaccines for Livestock Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Genetically Engineered Vaccines for Livestock Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Genetically Engineered Vaccines for Livestock Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Genetically Engineered Vaccines for Livestock Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Genetically Engineered Vaccines for Livestock Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Genetically Engineered Vaccines for Livestock Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Genetically Engineered Vaccines for Livestock Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Genetically Engineered Vaccines for Livestock Share of Global Market, 2018-2029
Figure 10. Global Genetically Engineered Vaccines for Livestock Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Genetically Engineered Vaccines for Livestock Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Genetically Engineered Vaccines for Livestock Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Genetically Engineered Vaccines for Livestock Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Genetically Engineered Vaccines for Livestock Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Genetically Engineered Vaccines for Livestock Domestic VS Export, 2022
Figure 16. Global Genetically Engineered Vaccines for Livestock Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Genetically Engineered Vaccines for Livestock Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Genetically Engineered Vaccines for Livestock Production Market Share & Forecast by Region, 2018-2029
Figure 19. Genetically Engineered Vaccines for Livestock Industry Chain
Figure 20. Genetically Engineered Vaccines for Livestock Procurement Model
Figure 21. Genetically Engineered Vaccines for Livestock Sales Model
Figure 22. Genetically Engineered Vaccines for Livestock Sales Channels, Direct Sales and Distribution
Figure 23. Genetic Recombinant Vaccine
Figure 24. Recombinant Subunit Vaccines
Figure 25. Genetic Vaccine
Figure 26. By Type, Global Genetically Engineered Vaccines for Livestock Revenue, 2018-2029, US$ Million
Figure 27. By Type, Global Genetically Engineered Vaccines for Livestock Revenue Market Share, 2018-2029
Figure 28. By Type, Global Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Figure 29. By Type, Global Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2018-2029
Figure 30. By Type, Global Genetically Engineered Vaccines for Livestock Price, 2018-2029, (US$/Unit)
Figure 31. Pig
Figure 32. Cattle
Figure 33. Sheep
Figure 34. Other
Figure 35. By Application, Global Genetically Engineered Vaccines for Livestock Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global Genetically Engineered Vaccines for Livestock Revenue Market Share, 2018-2029
Figure 37. By Application, Global Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global Genetically Engineered Vaccines for Livestock Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global Genetically Engineered Vaccines for Livestock Revenue Market Share, 2018-2029
Figure 41. By Region, Global Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2018-2029
Figure 42. North America Genetically Engineered Vaccines for Livestock Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Genetically Engineered Vaccines for Livestock Revenue Market Share, 2022
Figure 44. Europe Genetically Engineered Vaccines for Livestock Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Genetically Engineered Vaccines for Livestock Revenue Market Share, 2022
Figure 46. Asia Pacific Genetically Engineered Vaccines for Livestock Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Genetically Engineered Vaccines for Livestock Revenue Market Share, 2022
Figure 48. South America Genetically Engineered Vaccines for Livestock Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Genetically Engineered Vaccines for Livestock Revenue Market Share, 2022
Figure 50. Middle East & Africa Genetically Engineered Vaccines for Livestock Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. Genetically Engineered Vaccines for Livestock Market Share, 2022
Figure 53. By Type, U.S. Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe Genetically Engineered Vaccines for Livestock Market Share, 2022
Figure 57. By Type, Europe Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 59. China Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China Genetically Engineered Vaccines for Livestock Market Share, 2022
Figure 61. By Type, China Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan Genetically Engineered Vaccines for Livestock Market Share, 2022
Figure 65. By Type, Japan Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, South Korea Genetically Engineered Vaccines for Livestock Market Share, 2022
Figure 69. By Type, South Korea Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, South Korea Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 71. Southeast Asia Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Figure 72. By Company, Southeast Asia Genetically Engineered Vaccines for Livestock Market Share, 2022
Figure 73. By Type, Southeast Asia Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, Southeast Asia Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 75. India Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Figure 76. By Company, India Genetically Engineered Vaccines for Livestock Market Share, 2022
Figure 77. By Type, India Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, India Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 79. Middle East & Asia Genetically Engineered Vaccines for Livestock Sales Volume, 2018-2029, (K Units)
Figure 80. By Company, Middle East & Asia Genetically Engineered Vaccines for Livestock Market Share, 2022
Figure 81. By Type, Middle East & Asia Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, Middle East & Asia Genetically Engineered Vaccines for Livestock Sales Volume Market Share, 2022 VS 2029
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets